Efficacy and Optimal Timing of Endovascular Treatment for Type B Aortic Dissection
Overview
Authors
Affiliations
Objectives: To determine the efficacy and the optimal timing of thoracic endovascular aortic repair (TEVAR) for closing the primary entry in uncomplicated patients with chronic type B aortic dissection and a patent false lumen (FL).
Methods: Thirteen patients underwent TEVAR for aortic dissection between 2008 and 2012. These patients had chronic dissection with a patent FL and expansion of the aorta. Early TEVAR was performed for five patients within 1-7 months from the index dissection (TEVAR-EC group) and delayed TEVAR was performed for eight patients within 1-16 years (TEVAR-DC group). Changes in the diameters and volumes of the true lumen (TL) and FL and the aortic remodeling were assessed by multidetector computed tomography for 3 years after TEVAR.
Results: The reduction rate of FL in the thoracic aorta was notably higher in the TEVAR-EC group than in the TEVAR-DC group regardless of the presence or absence of distal retrograde flow. There was a significant TL expansion despite different timings of TEVAR.
Conclusions: Early TEVAR resulted in good prognosis and preferable aortic remodeling in uncomplicated patients with chronic type B aortic dissection and a patent FL, and we recommend early TEVAR within seven months after the index dissection.
Bai M, Li D, Xu K, Ouyang S, Yuan D, Zheng T Bioengineering (Basel). 2023; 10(2).
PMID: 36829632 PMC: 9951888. DOI: 10.3390/bioengineering10020139.
Omura A, Matsuda H, Fukuda T, Nomura Y, Kawasaki R, Murakami H Gen Thorac Cardiovasc Surg. 2019; 67(12):1021-1029.
PMID: 31041725 DOI: 10.1007/s11748-019-01128-0.
Virtual TEVAR: Overcoming the Roadblocks of In-Silico Tools for Aortic Dissection Treatment.
Diaz-Zuccarini V, Bonfanti M, Franzetti G, Balabani S Theranostics. 2019; 8(22):6384-6385.
PMID: 30613306 PMC: 6299687. DOI: 10.7150/thno.30753.
How should we manage type B aortic dissections?.
Fleerakkers J, Schepens M Gen Thorac Cardiovasc Surg. 2017; 67(1):154-160.
PMID: 28852959 DOI: 10.1007/s11748-017-0818-5.